Results 141 to 150 of about 2,694,366 (360)

Plecstatin inhibits hepatocellular carcinoma tumorigenesis and invasion through cytolinker plectin

Molecular Oncology, EarlyView.
The ruthenium‐based metallodrug plecstatin exerts its anticancer effect in hepatocellular carcinoma (HCC) primarily through selective targeting of plectin. By disrupting plectin‐mediated cytoskeletal organization, plecstatin inhibits anchorage‐dependent growth, cell polarization, and tumor cell dissemination.
Zuzana Outla, Jan Kosla, Magdalena Prechova, Lukas Frick, Patricia Bortel, Yasmin Borutzki, Andrea Bileck, Christopher Gerner, Samuel M. Meier‐Menches, Selma Osmanagic‐Myers, Martin Gregor   +10 more
wiley   +1 more source

Direct nucleic acid analysis of mosquitoes for high fidelity species identification and detection of Wolbachia using a cellphone [PDF]

, 2018
Sanchita Bhadra, Timothy E. Riedel, Miguel A. Saldaña, Shivanand Hegde, Nicole Pederson, Grant L. Hughes, Andrew D. Ellington   +6 more
openalex   +1 more source

Research on intelligent insect species identification based on computer vision [PDF]

, 2023
Bin Huang
openalex   +1 more source

Orthotrichum (Orthotrichaceae, Bryopsida) in Pakistan [PDF]

, 2002
A first critical survey of the genus Orthotrichum in Pakistan is provided. The currently known geographical distributions of the species and their ecologies within Pakistan are discussed.
Gruber, Johann Peter, Schäfer-Verwimp, Alfons   +1 more
core  

Therapeutic strategies for MMAE‐resistant bladder cancer through DPP4 inhibition

Molecular Oncology, EarlyView.
We established monomethyl auristatin E (MMAE)‐resistant bladder cancer (BC) cell lines by exposure to progressively increasing concentrations of MMAE in vitro. RNA sequencing showed DPP4 expression was increased in MMAE‐resistant BC cells. Both si‐DPP4 and the DPP4 inhibitor sitagliptin suppressed the viability of MMAE‐resistant BC cells.
Gang Li, Shuichi Tatarano, Hirofumi Yoshino, Saeki Saito, Mitsuhiko Tominaga, Junya Arima, Ikumi Fukuda, Takashi Sakaguchi, Ryosuke Matsushita, Yasutoshi Yamada, Hideki Enokida   +10 more
wiley   +1 more source

Identification of Clinically Relevant Mycobacterial Species after Extended Incubation Times in the BACTEC MGIT System [PDF]

, 2016
Bryan Rea, Julia R Maisel, Laurel Glaser, Kevin Alby   +3 more
openalex   +1 more source

Species identification of poultry egg products

Poultry Science, 2004
Species-specific primers for duck were deduced from the mitochondrial ATPase8 gene sequence. Species-specific PCR for turkeys and ducks showed no cross reaction with mixtures from chicken and guinea eggs and detection was possible to a concentration of 0.1% of homogenized duck egg and 5% of homogenized turkey egg when a PCR of 35 cycles was applied.
openaire   +2 more sources

Use of Subimages in Fish Species Identification: A Qualitative Study [PDF]

, 2011
Many scholarly tasks involve working with subdocuments, or contextualized fine-grain information, i.e., with information that is part of some larger unit.
Delcambre, Lois, Fox, Edward, Hallerman, Eric, Murthy, Uma, Pérez-Quiñones, Manuel, Torres, Ricardo, Tzy Li, Lin   +6 more
core   +1 more source

Infrared laser sampling of low volumes combined with shotgun lipidomics reveals lipid markers in palatine tonsil carcinoma

Molecular Oncology, EarlyView.
Nanosecond infrared laser (NIRL) low‐volume sampling combined with shotgun lipidomics uncovers distinct lipidome alterations in oropharyngeal squamous cell carcinoma (OPSCC) of the palatine tonsil. Several lipid species consistently differentiate tumor from healthy tissue, highlighting their potential as diagnostic markers.
Leonard Kerkhoff, Manuela Moritz, Dennis Eggert, Anna Worthmann, Joerg Heeren, Henrike Zech, Till S. Clauditz, Waldemar Wilczak, Hartmut Schlüter, Christian S. Betz, Arne Böttcher, Jan Hahn   +11 more
wiley   +1 more source

Recurrent cancer‐associated ERBB4 mutations are transforming and confer resistance to targeted therapies

Molecular Oncology, EarlyView.
We show that the majority of the 18 analyzed recurrent cancer‐associated ERBB4 mutations are transforming. The most potent mutations are activating, co‐operate with other ERBB receptors, and are sensitive to pan‐ERBB inhibitors. Activating ERBB4 mutations also promote therapy resistance in EGFR‐mutant lung cancer.
Veera K. Ojala, Sini Ahonen, Sara Peltola, Aura Tuohisto‐Kokko, Olaya Esparta, Peppi Suominen, Anne Jokilammi, Iman Farahani, Deepankar Chakroborty, Nikol Dibus, Steffen Boettcher, Tomi T. Airenne, Mark S. Johnson, Lisa D. Eli, Klaus Elenius, Kari J. Kurppa   +15 more
wiley   +1 more source